ascorbic acid/nausea

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 34 rezilta yo

The use of menadione bisulfite and ascorbic acid in the treatment of nausea and vomiting of pregnancy; a preliminary report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Comparative Evaluation of the Efficacy of Polyethylene Glycol With Ascorbic Acid and an Oral Sulfate Solution in a Split Method for Bowel Preparation: A Randomized, Multicenter Phase III Clinical Trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND An adequate level of bowel preparation before colonoscopy is important. The ideal agent for bowel preparation should be effective and tolerable. OBJECTIVE The purpose of this study was to compare the clinical efficacy and tolerability of polyethylene glycol with ascorbic acid and oral

A prospective randomized clinical study evaluating the efficacy and compliance of oral sulfate solution and 2-L ascorbic acid plus polyethylene glycol.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Oral sulfate solution (OSS) is an emerging cleansing agent for bowel preparation. However, data comparing OSS to other conventional bowel preparations in Asian patients are limited. Therefore, the objective of this study was to compare the efficacy and tolerability of OSS to ascorbic

Combination of bisacodyl suppository and 1L polyethylene glycol plus ascorbic acid (PEG-Asc) is a non-inferior and comfortable regimen compared to 2L PEG-Asc.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Appropriate bowel cleansing before colonoscopy is an important factor in increasing the detection rate of lesions. Low-volume polyethylene glycol (PEG) plus ascorbic acid (PEG-Asc) reduces the dosage of bowel preparation agent, but is still presents discomfort to

Effectiveness and safety of a new regimen of polyethylene glycol plus ascorbic acid for same-day bowel cleansing in constipated patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In an exploratory study we compared a new regimen of low-volume polyethylene glycol plus ascorbic acid (PEG-Asc) with the standard regimen for same-day bowel cleansing in constipated patients.Between January and June 2015 we studied consecutive patients

Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We conducted a single institution phase II trial to evaluate the tolerability and effectiveness of therapy with arsenic trioxide (ATO) and ascorbic acid (AA) with temozolomide (TMZ) in patients with advanced melanoma. Planned enrollment was for 40 patients. Eligible patients were required to have

Possible warfarin resistance due to interaction with ascorbic acid: case report and literature review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE A potential interaction involving therapeutic doses of ascorbic acid and warfarin is described. CONCLUSIONS A 65-year-old Caucasian man with chronic cardiac and pulmonary disorders was admitted to the emergency room for chest pain, shortness of breath, nausea, and diaphoresis. Imaging

[Cystinuria therapy by ascorbic acid (author's transl)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

At the beginning of the four chapters on phenomena, analysis, pathophysiology and therapy of cystinuria the essentials of the published literature are summarized. The frequency of cystinuria is in the order of 1:10,000. Besides the cystine lithiasis occurring in nine tenths of all cystinuria

Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Oral intake of ascorbic acid is essential for optimum health in human beings. Continuous ambulatory peritoneal dialysis (CAPD) patients have an increased need for ascorbic acid, because of increased loss through dialysate, reduced intake owing to nausea and loss of appetite, and increased oxidative

Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Intravenous ascorbic acid (IVAA) administration is reported to enhance erythropoiesis in hemodialysis (HD) patients with functional iron deficiency. We explored the effects of IVAA on erythropoiesis and health-related quality of life (HRQOL) in unselected HD patients. METHODS Sixty-one HD

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA. The purpose of this study was to expand the current literature using a retrospective analysis of adverse events

Polyethylene glycol plus ascorbic acid is as effective as sodium picosulfate with magnesium citrate for bowel preparation: A randomized trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE This study was aimed to evaluate the efficacy and safety of two low-volume agents, polyethylene glycol (PEG)-3350 plus ascorbic acid (PEG + Asc) and sodium picosulfate with magnesium citrate (SPMC), for bowel preparation. METHODS We performed a prospective, endoscopist-blinded,

Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate the effectiveness of low-volume plus ascorbic acid [polyethylene glycol plus ascorbic acid (PEG + Asc)] and high-volume plus simethicone [polyethylene glycol plus simethicone (PEG + Sim)] bowel preparations. METHODS A total of one hundred and forty-four outpatients (76

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Preclinical studies suggest synergistic effectiveness of ascorbic acid (AA, vitamin C) and cytotoxic agents in gastrointestinal malignancies. This phase 1 study aimed to establish the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of AA combined with mFOLFOX6 or

A meta-analysis of randomized controlled trials of low-volume polyethylene glycol plus ascorbic acid versus standard-volume polyethylene glycol solution as bowel preparations for colonoscopy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Standard-volume polyethylene glycol (PEG) gut lavage solutions are safe and effective, but they require the consumption of large volumes of fluid. A new lower-volume solution of PEG plus ascorbic acid has been used recently as a preparation for colonoscopy. OBJECTIVE A meta-analysis was

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye